The breast cancer treatment as a marker of progress in oncology

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 190-194

  Bilynskyj, B T ^a  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Breast cancer; Diagnostics; Fundamental investigations; Perspective; Treatment

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; EXEMESTANE; FULVESTRANT; LETROZOLE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; REVIEW;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; MEDICAL ONCOLOGY;

EID: 77957731070     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kavetsky RE. Host - tumor interactions. Kiev: Naukova Dumka, 1977. 235 p. (In Russian).
2. Gnatyshak AI. Tutorial on general clinical oncology. Moscow: Meditsina 1975. 216 p. (In Russian).
3. Berezhnaya NM, Chekhun VF. System of interleukines and cancer. Kyiv: DIA, 2000. 224 p. (In Russian).
4. Bilynskyj BT, Shparik YV. Actual problems of drug therapy of breast cancer. Lviv: Galitska Vydavnycha Spilka, 2001. 156 p. (In Ukrainian).
5. Madej G. Chemoterapia onkologiczna doroslych i dzieci. Warszawa: Wyd Lek PZWL, 1994. 315 p. (In Polish).
6. Bilynskyj BT. Breast tumor as general medical problem. Mezhdunarod Med J 2002; 8: 111-7 (in Russian).
7. Galay OO. Complex diagnostics of lesions of mediastinum lymphonodes in breast cancer patients. Kyiv: MD Thesis, 1996. 20 p. (In Ukrainian).
8. Oliynik YY. Influence of enterosorbtion with aerosil on toxic effects of polychemotherapy in breast cancer patients. Kyiv: MD Thesis, 1994. 20 p. (In Ukrainian).
9. Bilynskyj BT. Implant recurrences of breast tumor and their relation to cancer cells in wound under mastectomy. Lviv: MD Thesis, 1963. 20 p. (In Russian).
10. Bilynskyj BT. Recurrences of breast cancer. Clin Chirurgia 1964; 9: 48-55 (in Russian).
11. Bilynskyj BT, Gnatyshak AI, Savran VR. Oncologia. Lviv: Svit, 1992; 288 p. (In Ukrainian).
12. Bilynskyj BT. Evolution of viewpoints of treatment of breast cancer. Acta Medica Leopoliensia 1995; 1: 25-9 (in Ukrainian).
13. Bilynskyj B. Die historische Entwicklung der Behandlung des Mammakarcinoms. Europeische Seminar fur Chirurgische Onkologie I. Lwiw, 1992. (In German).
14. Winchester DP. Putting prophylactic mastectomy in proper perspective. Cancer J Clin 1995; 45: 261.
15. Bilynskyj BT. Treatment of breast cancer: retrospection, state-of-the-art, perspective. J Acad Med Sci of Ukraine 1999; 5: 544-55 (in Ukrainian).
16. Andre F. Neoadjuvant chemotherapy for breast cancers: current recommendations and future directions. Congress ESMO 2009, Scientific programme, 21.
17. Berger J, Liberski P, Pluzanska A, et al. Zarys oncologii. Lodz, 1998. 304 p. (In Polish).
18. Bilynskyj BT. Treatment of breast cancer in historical aspects. Acta Chirurgica Austriaca 1995; Suppl 113. 3 p.
19. Caldas C. Triple negative breast cancer: clinical and prognostic implications. ESMO 2009, 34. Scientific programme.
20. Jackish C. Therapeutic approach of early and advanced triple negative breast cancer. In: Clinical relevance of the triple negative breast cancer concept. ECCO 2009, 15.
21. Hetelekidis S, Schnitt SJ, Morrow M, et al. Management of ductal carcinoma «in situ». Cancer J Clin 1995; 45: 244-53.
22. Mettlin C. Global breast cancer mortality statistics. Cancer J Clin 1999; 49: 138-44. (Pubitemid 29353927)
23. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: Devite VT, Hellman S, Rosenberg SA, eds. Principles and practice of oncology, 4-th ed. Philadelphia: J.B. Lippincott Co, 1993: 1264-332.
24. Shparik YV, Bilynskyj BT. Adjuvant chemotherapy of breast cancer. Lviv: Acta-medica Ukraina, 1997. 65 p. (In Ukrainian).
25. Shparik YV. Hormonal therapy of breast cancer: the role of letrosole. Lviv: Galitska Vydavnycha Spilka, 2001. 95 p. (in Ukrainian).
26. Viale G. Pathological definition of triple negative breast cancer. In: Clinical relevance of the triple negative breast cancer concept. ESMO 2009, 34. Scientific programme.
27. Hortobagyi GN, Burdar A. Current status of adjuvant systemic therapy for primary breast cancer. Progress and controversy. Cancer J Clin 1995; 45: 199-226.
28. Bilynskyj BT, Savran VR. Present tendencies in the surgical treatment of breast cancer. XXV Congress chirurgicus. Bohemoslovacae: Brunna, 1989: 11-13.
29. Osinsky S, Vaupel P. Tumor microphysiology. Kiev: Naukova Dumka, 2009. 254 p. (In Russian).
30. Grinevich YA, Kamenets LY, Bilynskyj BT, et al. Immunology and immunotherapy of breast cancer. Kiev: Zdorovie 1990. 176 p. (In Russian).